Avacincaptad pegol
Avacincaptad pegol, sold under the brand name Izervay, is a medication used for the treatment of age-related macular degeneration. Avacincaptad pegol is a complement inhibitor.
Avacincaptad pegol was approved for medical use in the United States in August 2023.